Avery Alexander, MD
Ophthalmology · Appleton, WINPI 1982788030
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 133 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Alcon accounts for 81.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $2,337 and has fallen 55.0% since, to $1,052 in 2025. Among ophthalmology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 133 payments — averaging $65.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$7K
- Johnson & Johnson Surgical Vision, Inc.$993
- Bausch & Lomb Americas Inc.$197
- Bausch & Lomb, A Division Of Bausch Health US, LLC$175
- The Cameron-ehlen Group, Inc.$130
- Carl Zeiss Meditec USA, Inc.$85
- plus $33 from 1 others
What the payments were for
- Food & beverage$8,698100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 105 | $7,086 |
| Johnson & Johnson Surgical Vision, Inc. | 14 | $993 |
| Bausch & Lomb Americas Inc. | 5 | $197 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $175 |
| The Cameron-ehlen Group, Inc. | 5 | $130 |
| Carl Zeiss Meditec USA, Inc. | 1 | $85 |
| Rxsight Inc | 1 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AcrySof IQ PanOptix$663
- AcrySof IQ VIVITY IOL$459
- ReSTOR$336
- Centurion$214
- Clareon$206
- Tecnis IOL$146
- CATALYS SYSTEM$127
- Luxor$116
- AcrySof$115
How this compares
$8,698 in reported general payments places this provider in the 95th percentile of 337 ophthalmology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProlensaBromfenac Sodium | 58 | $20,252 |
| Lotemax SmLoteprednol Etabonate | 77 | $19,906 |
| LumiganBimatoprost | 28 | $14,874 |
| VyzultaLatanoprostene Bunod | 28 | $12,241 |
| Latanoprost | 828 | $9,929 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 483 | $8,523 |
| Ofloxacin | 116 | $1,236 |
| Betaxolol Hcl | 17 | $985 |
| Timolol Maleate | 59 | $935 |
| ErythromycinErythromycin Base | 29 | $260 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 38 | $238 |
| Ibuprofen | 18 | $56 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLCProlensa, Lotemax Sm | $175 | $40,159135 claims |
| Bausch & Lomb Americas Inc.Vyzulta | $197 | $12,24128 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 337 ophthalmology providers in Wisconsin.
Other ophthalmology in Appleton
- Douglas SalmAppleton$38K
- Michael VrabecAppleton$20K
- Inder SinghRacine$2.5M
- Deepak SambharaWausau$388K
- John VukichWauwatosa$356K
- Eugene EldridgeKenosha$294K
- Michael ShapiroMadison$71K
- Julia AgapovMadison$26K
- Thomas HarveyChippewa Falls$23K
- Philip SmithMinocqua$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.